Literature DB >> 33780215

Associations of Habitual Dietary Intake With Fecal Short-Chain Fatty Acids and Bowel Functions in Irritable Bowel Syndrome.

Gerardo Calderon1, Chirag Patel1, Michael Camilleri2, Toyia James-Stevenson1, Matthew Bohm1, Robert Siwiec1, Nicholas Rogers1, John Wo1, Carolyn Lockett1, Anita Gupta1, Huiping Xu3, Andrea Shin1.   

Abstract

BACKGROUND GOALS: Diet may contribute to symptoms of irritable bowel syndrome (IBS) and luminal production of putative IBS biomarkers including short-chain fatty acids (SCFAs). Study aims were to to assess relationships of habitual fiber or starch intake with fecal SCFAs in patients with IBS and healthy volunteers (HVs). STUDY: In 18 HVs and 30 patients with IBS (13 constipation-predominant [IBS-C] and 17 diarrhea-predominant [IBS-D]), habitual diet using a food frequency questionnaire; bowel functions using a validated bowel diary; and fecal SCFAs by HPLC-mass spectrometry were assessed. Associations of fiber and starch with SCFAs were analyzed using Spearman (rs) and Pearson (R) correlations. Relationships between other dietary endpoints, SCFAs, and bowel functions were explored.
RESULTS: Habitual fiber or starch intakes were not significantly correlated with SCFAs or bowel functions in all participants or HVs nor with SCFAs in IBS. Starch was negatively correlated (R=-0.53; P=0.04) with complete evacuation in IBS-D. Fiber (rs=0.65; P=0.02) and starch (rs=0.56; P=0.05) were correlated with ease of passage in IBS-C. Stool form, frequency, and ease of passage were positively correlated with total SCFAs (all P<0.05), acetate (all P<0.01), propionate (all P<0.05), and butyrate (form P=0.01; ease of passage P=0.05) among all participants, but not in IBS. Complete evacuation was negatively correlated with propionate (R=-0.34; P=0.04) in all participants. Total (P=0.04) and individual SCFAs (all P<0.05) were positively correlated with stool form in HVs.
CONCLUSIONS: Habitual fiber and starch intake does not influence fecal SCFAs but may influence bowel functions in IBS. Fecal SCFAs correlate with bowel functions among all participants including HVs.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 33780215      PMCID: PMC8435047          DOI: 10.1097/MCG.0000000000001521

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  58 in total

1.  Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa.

Authors:  Carlotta De Filippo; Duccio Cavalieri; Monica Di Paola; Matteo Ramazzotti; Jean Baptiste Poullet; Sebastien Massart; Silvia Collini; Giuseppe Pieraccini; Paolo Lionetti
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-02       Impact factor: 11.205

2.  Stimulatory effects of short-chain fatty acids on colonic absorption in newborn piglets in vivo.

Authors:  R D Murray; H J McClung; B U Li; A Ailabouni
Journal:  J Pediatr Gastroenterol Nutr       Date:  1989-01       Impact factor: 2.839

Review 3.  Irritable Bowel Syndrome: Pathophysiology and Current Therapeutic Approaches.

Authors:  Michael Camilleri; Alexander C Ford
Journal:  Handb Exp Pharmacol       Date:  2017

Review 4.  Biomarkers as a diagnostic tool for irritable bowel syndrome: where are we?

Authors:  Michael Camilleri; Houssam Halawi; Ibironke Oduyebo
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2017-02-13       Impact factor: 3.869

5.  Food-related quality of life in patients with inflammatory bowel disease and irritable bowel syndrome.

Authors:  Livia Guadagnoli; Ece A Mutlu; Bethany Doerfler; Ammoura Ibrahim; Darren Brenner; Tiffany H Taft
Journal:  Qual Life Res       Date:  2019-03-21       Impact factor: 4.147

6.  Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome.

Authors:  C Tana; Y Umesaki; A Imaoka; T Handa; M Kanazawa; S Fukudo
Journal:  Neurogastroenterol Motil       Date:  2009-11-10       Impact factor: 3.598

7.  Pharmacodynamic and clinical endpoints for functional colonic disorders: statistical considerations.

Authors:  Alan R Zinsmeister; Duane Burton; Michael Camilleri
Journal:  Dig Dis Sci       Date:  2012-08-24       Impact factor: 3.199

8.  Pain is temporally related to eating but not to defaecation in the irritable bowel syndrome (IBS). Patients' description of diarrhea, constipation and symptom variation during a prospective 6-week study.

Authors:  G Ragnarsson; G Bodemar
Journal:  Eur J Gastroenterol Hepatol       Date:  1998-05       Impact factor: 2.566

9.  Altered Colonic Bacterial Fermentation as a Potential Pathophysiological Factor in Irritable Bowel Syndrome.

Authors:  Tamar Ringel-Kulka; Chang Hwan Choi; Daniel Temas; Ari Kim; Daniele M Maier; Karen Scott; Joseph A Galanko; Yehuda Ringel
Journal:  Am J Gastroenterol       Date:  2015-08-25       Impact factor: 10.864

10.  Economic burden of moderate to severe irritable bowel syndrome with constipation in six European countries.

Authors:  Jan Tack; Vincenzo Stanghellini; Fermín Mearin; Yan Yiannakou; Peter Layer; Benoit Coffin; Magnus Simren; Jonathan Mackinnon; Gwen Wiseman; Anne Marciniak
Journal:  BMC Gastroenterol       Date:  2019-05-07       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.